Journal article
MUC1-mediated Macrophage Activation Promotes Colitis-associated Colorectal Cancer via Activating the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Axis
YH Sheng, JM Davies, R Wang, KY Wong, R Giri, Y Yang, J Begun, TH Florin, SZ Hasnain, MA McGuckin
Cellular and Molecular Gastroenterology and Hepatology | Published : 2022
Abstract
Background & Aims: MUC1 is abnormally expressed in colorectal cancer, including colitis-associated colorectal cancer (CAC), but its role in tumorigenesis is unclear. This study investigated MUC1’s effects in murine models of colitis and CAC and elucidated mechanisms of action. Methods: Colitis and CAC were induced in mice by exposure to dextran sodium sulfate or azoxymethane plus dextran sodium sulphate. Clinical parameters, immune cell infiltration, and tumor development were monitored throughout disease progression. Experiments in knockout mice and bone marrow chimeras were combined with an exploration of immune cell abundance and function. Results: Deficiency of Muc1 suppressed inflammati..
View full abstractGrants
Awarded by Mater Foundation
Funding Acknowledgements
This study was supported by National Health and Medical Research Council project grants 1060698 and 1164141, and funding by the Mater Foundation. Yong Hua Sheng was partly supported by a Gastroenterological Society of Australia Mostyn Family Grant and Gastroenterological Society of Australia Project Grant. The Translational Research Institute is supported by a grant from the Australian Government.